Product Code: CMI2847
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.
Market Dynamics
New strategies adopted by key players related to outsourcing drug discovery is expected to drive growth of global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.
Furthermore, extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2021, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to the preclinical drug development for treatment of respiratory diseases and rare diseases.
Key features of the study:
- This report provides in-depth analysis of the outsourced drug discovery market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global outsourced drug discovery market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd. Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global outsourced drug discovery market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Outsourced Drug Discovery Market, By Drug Type:
- Small Molecule Drugs
- Large Molecule Drugs
- Global Outsourced Drug Discovery market, By Services:
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- Global Outsourced Drug Discovery Market, By Application
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- Global Outsourced Drug Discovery market, By End User
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Global Outsourced Drug Discovery market, By Region:
- North America
- U.S.
- Canada
- Small Molecule Drugs
- Large Molecule Drugs
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Europe
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Small Molecule Drugs
- Large Molecule Drugs
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Asia Pacific
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Small Molecule Drugs
- Large Molecule Drugs
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Small Molecule Drugs
- Large Molecule Drugs
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Middle East
- GCC
- Israel
- Rest of Middle East
- Small Molecule Drugs
- Large Molecule Drugs
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Africa
- South Africa
- Central Africa
- North Africa
- Small Molecule Drugs
- Large Molecule Drugs
- Preclinical Development
- Target Validation and Functional Informatics
- Target Identification and Screening
- Lead Identification and Candidate Optimization
- Others
- Oncology
- Ophthalmology
- Hematology
- Immunomodulation
- Anti-Infective Drugs
- Dermatology
- Pulmonology
- Cardiology
- Others
- Pharmaceutical and Biotechnological Companies
- Contract Research Organization
- Contract Manufacturing Organization
- Company Profiles
- Aurigene Accelerating Discovery,*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bioduro LLC.
- Charles River Laboratories (CRL)
- TCG Lifesciences
- Evotec AG
- Syngene International Ltd.
- Jubilant Biosys Ltd.
- Pharmaron Inc.
- Shanghai Medicilon Inc.
- Sundia Meditech Co. Ltd.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Services
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Technology Advancements
- Historical Overview
- Merger and Acquisition
- Regulatory Scenario
- PORTER'S Five Forces
- PEST Analysis
4. Global Outsourced Drug Discovery Market, By Drug Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Small Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Large Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
5. Global Outsourced Drug Discovery Market, By Services, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Preclinical Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Target Validation and Functional Informatics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Target Identification and Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Lead Identification and Candidate Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Outsourced Drug Discovery Market, By Application, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Ophthalmology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Hematology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Immunomodulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Anti-Infective Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Pulmonology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
7. Global Outsourced Drug Discovery Market, By End Users, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Pharmaceutical and Biotechnological Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Contract Research Organization (CRO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Contract Manufacturing Organization (CMO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Outsourced Drug Discovery Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Services, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
9. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Aurigene Accelerating Discovery
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bioduro LLC.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Charles River Laboratories (CRL)
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- TCG Lifesciences
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Evotec AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Syngene International Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Jubilant Biosys Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pharmaron Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Shanghai Medicilon Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Sundia Meditech Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Analyst Views
10. Section
- References
- Research Methodology
- About us and Sales Contact